Man Group plc - CYTOMX THERAPEUTICS INC ownership

CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 143 filers reported holding CYTOMX THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 0.09 and the average weighting 0.1%.

Quarter-by-quarter ownership
Man Group plc ownership history of CYTOMX THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$75,953
+37.3%
50,300
+45.5%
0.00%
Q4 2022$55,320
+53.7%
34,575
+36.0%
0.00%
Q3 2022$36,000
-47.1%
25,430
-32.2%
0.00%
Q2 2022$68,000
-80.8%
37,501
-18.5%
0.00%
-100.0%
Q1 2021$355,000
-79.7%
45,988
-82.8%
0.00%
-75.0%
Q4 2020$1,749,000
+18.6%
266,986
+20.4%
0.01%
+33.3%
Q3 2020$1,475,000
-8.9%
221,812
+14.1%
0.01%
-25.0%
Q2 2020$1,619,000
-22.5%
194,412
-28.6%
0.01%
-42.9%
Q1 2020$2,089,000
-21.6%
272,410
-15.0%
0.01%
+55.6%
Q4 2019$2,665,000
+3406.6%
320,655
+2999.3%
0.01%
Q3 2019$76,000
-91.4%
10,346
-87.4%
0.00%
-100.0%
Q1 2019$879,000
-57.6%
81,798
-40.4%
0.00%
-66.7%
Q4 2018$2,073,000
-36.4%
137,261
-22.1%
0.01%
-25.0%
Q3 2018$3,259,000
-60.6%
176,160
-51.3%
0.01%
-64.7%
Q2 2018$8,270,000
-28.7%
361,750
-11.2%
0.03%
-35.8%
Q1 2018$11,593,000407,4830.05%
Other shareholders
CYTOMX THERAPEUTICS INC shareholders Q2 2018
NameSharesValueWeighting ↓
BVF INC/IL 5,803,700$25,130,0000.91%
Altium Capital Management LP 663,800$2,874,0000.79%
Rubric Capital Management LP 2,406,449$10,420,0000.49%
RTW INVESTMENTS, LP 6,029,700$26,109,0000.38%
Orbimed Advisors 3,214,509$13,919,0000.18%
TANG CAPITAL MANAGEMENT LLC 152,345$660,0000.13%
PLATINUM INVESTMENT MANAGEMENT LTD 980,085$4,244,0000.12%
Point72 Asset Management, L.P. 6,303,025$27,292,0000.11%
Sender Co & Partners, Inc. 40,720$176,0000.09%
Manteio Capital LLC 15,067$65,0000.08%
View complete list of CYTOMX THERAPEUTICS INC shareholders